https://cytoskeletalsignalingi....nhibitor.com/index.p
In propensity score-adjusted analyses, the BNT162b2 vaccine group showed a significantly lower rate of COVID-19 hospitalizations compared to the ChAdOx1 vaccine group. This is evident through a relative difference of -0.009 (95% CI -0.013 to -0.005 per 1000 person-months) and a hazard ratio of 0.65 (95% CI 0.57 to 0.74). There was no marked difference in the probability of death from COVID-19 between the two comparison populations. A study e
Like
Comment
Share
